Literature DB >> 8894686

Treacher Collins syndrome may result from insertions, deletions or splicing mutations, which introduce a termination codon into the gene.

A J Gladwin1, J Dixon, S K Loftus, S Edwards, J J Wasmuth, R C Hennekam, M J Dixon.   

Abstract

Treacher Collins syndrome is an autosomal dominant disorder of craniofacial development the features of which include conductive hearing loss and cleft palate. Recently, the Treacher Collins syndrome gene (TCOF1) has been positionally cloned and a series of five mutations within the coding sequence of the gene identified. In the current investigation, seven exons of TCOF1 have been identified which has permitted the identification of additional mutations in the gene. The mutations that have been identified are three distinct deletions and an insertion, which cause a frameshift, and a missense mutation which inactivates a donor splice site with extension of transcription into the intron. To date, all 10 of the mutations which have been reported result in a premature termination codon and are unique to a given family. As these mutations are spread throughout the gene, these observations provide further support for the hypothesis that Treacher Collins syndrome results from haploinsufficiency, although a dominant negative effect cannot, at this stage, be excluded.

Entities:  

Mesh:

Year:  1996        PMID: 8894686     DOI: 10.1093/hmg/5.10.1533

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  22 in total

Review 1.  Craniofacial birth defects: The role of neural crest cells in the etiology and pathogenesis of Treacher Collins syndrome and the potential for prevention.

Authors:  Paul A Trainor
Journal:  Am J Med Genet A       Date:  2010-08-23       Impact factor: 2.802

2.  Gross deletions in TCOF1 are a cause of Treacher-Collins-Franceschetti syndrome.

Authors:  Michael Bowman; Michael Oldridge; Caroline Archer; Anthony O'Rourke; Joanna McParland; Roel Brekelmans; Anneke Seller; Tracy Lester
Journal:  Eur J Hum Genet       Date:  2012-02-08       Impact factor: 4.246

Review 3.  Facial dysostoses: Etiology, pathogenesis and management.

Authors:  Paul A Trainor; Brian T Andrews
Journal:  Am J Med Genet C Semin Med Genet       Date:  2013-10-04       Impact factor: 3.908

4.  The mutational spectrum in Treacher Collins syndrome reveals a predominance of mutations that create a premature-termination codon.

Authors:  S J Edwards; A J Gladwin; M J Dixon
Journal:  Am J Hum Genet       Date:  1997-03       Impact factor: 11.025

Review 5.  Zebrafish models of orofacial clefts.

Authors:  Kaylia M Duncan; Kusumika Mukherjee; Robert A Cornell; Eric C Liao
Journal:  Dev Dyn       Date:  2017-09-25       Impact factor: 3.780

Review 6.  Rare syndromes of the head and face: mandibulofacial and acrofacial dysostoses.

Authors:  Karla Terrazas; Jill Dixon; Paul A Trainor; Michael J Dixon
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2017-02-10       Impact factor: 5.814

Review 7.  Face off against ROS: Tcof1/Treacle safeguards neuroepithelial cells and progenitor neural crest cells from oxidative stress during craniofacial development.

Authors:  Daisuke Sakai; Paul A Trainor
Journal:  Dev Growth Differ       Date:  2016-08-02       Impact factor: 2.053

Review 8.  Ribosome biogenesis in skeletal development and the pathogenesis of skeletal disorders.

Authors:  Paul A Trainor; Amy E Merrill
Journal:  Biochim Biophys Acta       Date:  2013-11-16

9.  First Report of a Single Exon Deletion in TCOF1 Causing Treacher Collins Syndrome.

Authors:  J Beygo; K Buiting; S Seland; H-J Lüdecke; U Hehr; C Lich; B Prager; D R Lohmann; D Wieczorek
Journal:  Mol Syndromol       Date:  2012-01-26

10.  Reduced transcription of TCOF1 in adult cells of Treacher Collins syndrome patients.

Authors:  Cibele Masotti; Camila C Ornelas; Alessandra Splendore-Gordonos; Ricardo Moura; Têmis M Félix; Nivaldo Alonso; Anamaria A Camargo; Maria Rita Passos-Bueno
Journal:  BMC Med Genet       Date:  2009-12-14       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.